| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.019 | 0.5 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.035 | 0.5 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.04 | 0.5 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |